Neal Hurst

Neal Hurst serves as a procurement professional specializing in medical and laboratory supply acquisitions, playing a critical role in advancing agency capabilities within the healthcare technology and diagnostics sector. He manages a diverse portfolio of contracts under the Federal Acquisition Regulation, focusing on the acquisition of surgical instruments, in-vitro diagnostic substances, and medical laboratory services. His work ensures timely delivery of mission-critical healthcare products while adhering to stringent regulatory and quality standards. Hurst’s acquisitions support operational readiness and clinical infrastructure, often requiring compliance with FDA and CLIA guidelines, and he frequently coordinates with technical specialists to evaluate product performance and lifecycle requirements. His contractor relationships center on manufacturers and distributors of precision medical devices and diagnostic solutions, including firms with expertise in sterile packaging, ISO 13485 certification, and FDA-registered production facilities. He engages both large-tier suppliers and small business vendors, fostering long-term partnerships grounded in performance-based contracting and supply chain resilience. His approach emphasizes vendor reliability, regulatory compliance, and post-award surveillance to ensure consistent product quality and delivery. Hurst demonstrates a strong commitment to small business participation, with nearly one-fifth of his awards designated as total small business set-asides under FAR 19.5. While the majority of his acquisitions remain open to all competitors, he actively leverages small business programs to promote innovation and market diversity, particularly among firms certified as small business concerns with no other socioeconomic preference. His primary procurement focus lies in NAICS 339112 (surgical instrument manufacturing), 325413 (in-vitro diagnostic substances), and 621511 (medical laboratories), reflecting deep expertise in diagnostic testing infrastructure, sterile medical supplies, and blood and organ banking systems. He routinely evaluates technical specifications for assay kits, lab automation equipment, and single-use surgical devices, ensuring acquisitions align with clinical best practices and evolving public health needs.